Sheets et al.
2-Benzhydryl-1-methyl-1H-imidazole (6). Using general proce-
dure A, compound 1 is reacted with C6H6 and CF3SO3H. Product
6 is isolated. 1H NMR (CDCl3): δ 3.47 (s, 3H), 5.51 (s, 1H), 6.87
(s, 1H), 7.05 (s, 1H), 7.20-7.35 (m, 10H). 13C NMR (CDCl3): δ
32.9, 49.5, 121.0, 126.9, 127.6, 128.6, 128.9, 141.0, 148.7. Low
resolution MS (EI): 248 (M+), 247, 165. High resolution MS (EI),
C17H16N2 calcd: 248.13135, found 248.13070.
5-Benzhydryl-4-methyl-1H-imidazole (8). Using general proce-
dure A, compound 3 is reacted with C6H6 and CF3SO3H. Product
8 is isolated. 1H NMR (CDCl3): δ 2.07 (s, 3H), 5.39 (s, 1H),
7.10-7.44 (m, 10), 11.7 (m, 1H). 13C NMR (CDCl3): δ 10.0, 48.3,
126.2, 128.4, 129.2, 133.7, 122.5, 145.1. Low resolution MS (EI):
248 (M+), 247, 233, 171. High resolution MS (EI), C17H16N2 calcd:
248.13135, found 248.13140.
δ 44.7, 49.9, 119.3, 123.6, 127.1, 127.5, 127.9, 128.2, 128.3, 128.6,
128.9, 129.4, 135.4, 140.8, 144.1. Low resolution MS (EI): 246
(M+), 245, 169, 128. High resolution MS (EI), C17H14N2 calcd:
246.1157, found 246.1153.
6-Methyl-1-phenyl-5,6-dihydroimidazo[5,1-a]isoquinoline (29).
4,5-Diphenyl-imidazole (0.5 g, 2.2 mmol) is dissolved in 20 mL
of anhydrous ether, and KOtBu (0.27 g, 2.4 mmol) is then added
at 25 °C. The mixture is stirred at 25 °C for 30 min, and then allyl
bromide (0.2 mL, 2.3 mmol) is added. After 30 min of stirring, the
solution is partitioned between ether and water. The organic phase
is then washed twice with brine and dried over magnesium sulfate.
Further purification is achieved by column chromatography (silica
gel; hexane/ether). The 1-allyl-4,5-diphenyl-1H-imidazole (27) is
reacted with CF3SO3H according to general procedure B. Product
1
5-(Bis(2,4-dichlorophenyl)methyl)-4-methyl-1H-imidazole (9). Us-
29 is isolated. H NMR (CDCl3): δ 1.35 (d, J ) 7.0 Hz, 3H),
ing general procedure A, compound 3 is reacted with 1,3-
3.22-3.29 (m, 1H), 3.91 (dd, J ) 12.2, 5.7 Hz, 1H), 4.14 (dd, J )
12.2, 4.4 Hz, 1H), 7.12-7.15 (m, 1H), 7.20-7.23 (m, 1H),
7.29-7.31 (m, 1H), 7.33-7.36 (m, 1H), 7.41-7.44 (m, 2H), 7.60 s,
1H), 7.64 (d, J ) 7.8 Hz, 1H), 7.74-7.76 (m, 2H). 13C NMR
(CDCl3): δ 18.1, 34.1, 48.4, 123.6, 124.3, 126.7, 127.0, 127.2, 127.3,
128.4, 128.4, 135.7, 135.7, 137.2, 138.0, 143.6. Low resolution MS
(EI): 260 (M+), 259, 218, 115. High resolution MS (EI), C18H16N2
calcd: 260.13135, found 260.13086.
1
dichlorobenzene and CF3SO3H. Product 10 is isolated. H NMR
(CDCl3): δ 2.11 (s, 1H), 5.98 (s, 1H), 7.08-7.16 (m, 4H), 7.39 (s,
3H). 13C NMR (CDCl3): δ 9.8, 41.7, 127.0, 129.4, 131.2, 133.1,
133.5, 134.7, 138.3. Low resolution MS (EI): 388/386/384 (M+),
351/349, 313, 239. High resolution MS (EI), C17H12Cl4N2 calcd:
383.97545, found 383.97563.
1-Methyl-2-(1,1-diphenylethyl)-1H-imidazole (11). Using general
procedure A, compound 5 is reacted with C6H6 and CF3SO3H.
6-Methyl-5,6-dihydroimidazo[2,1-a]isoquinoline (32). Similar to
the procedure for compound 25, 1-allyl-2-phenyl-1H-imidazole (30)
is prepared by reaction of 2-phenylimidazole and allyl bromide and
it is reacted with CF3SO3H according to general procedure B.
1
Product 11 is isolated. H NMR (CDCl3): δ 2.23 (s, 1H), 2.90 (s,
3H), 6.78 (d, J ) 1.0 Hz, 1H), 7.06, (d, J ) 1.0 Hz, 1H), 7.14-7.31
(m, 10H). 13C NMR (CDCl3): δ 32.7, 34.9, 50.6, 122.7, 126.5,
126.6, 127.9, 128.4, 145.0, 152.0. Low resolution MS (EI): 262
(M+), 261, 246, 171, 103. High resolution MS (EI), C18H18N2 calcd:
262.1470, found 262.1470.
1
Product 32 is isolated. H NMR (CDCl3): δ 1.33 (d, J ) 7.0 Hz,
3H), 3.27-3.31 (m, 1H), 3.91 (dd, J ) 12.4, 5.9 Hz, 1H), 4.21
(dd, J ) 12.4, 5.1 Hz, 1H), 6.94 (s, 1H), 7.17 (s, 1H), 7.27-7.37
(m, 3H), 8.05-8.07 (m, 1H). 13C NMR (CDCl3): δ 19.0, 33.2, 49.6,
119.3, 123.7, 126.3, 126.4, 127.5, 128.6, 129.2, 137.6, 143.9. Low
resolution MS (EI): 184 (M+), 169, 128, 84. High resolution MS
(EI), C12H12N2 calcd: 184.1001, found 184.0996.
General Procedure B for the Intramolecular Cyclizations of
Imidazole Alcohols and Olefins. The imidazole substrate (1 mmol)
is dissolved in CHCl3, and CF3SO3H (3 mL, 33 mmol) is added.
Depending on the substrate the solution may be heated. The reaction
is stirred at least 2 h and then poured over several grams of ice. The
mixture is made basic (pH paper) with the slow addition of 10 M
NaOH. The resulting solution is extracted twice with CHCl3, and the
combined organic extracts are further washed with water (once) and
then brine (twice). If purification is necessary, the product mixture is
subjected to column chromatography (silica gel; hexane/ether).
1-Phenylimidazo[5,1-a]isoquinoline (23). 4,5-Diphenylimidazole
(0.5 g, 2.3 mmol) is dissolved in 20 mL of anhydrous THF, KOtBu
(0.26 g, 2.3 mmol) is added, and the mixture is stirred at 25 °C for
1 h. To this mixture is added dropwise a styrene oxide (0.3 g, 2.5
mmol) solution in 10 mL of THF, and the final solution is then
refluxed for 1 h. The product mixture is then diluted with water
and extracted three times with ether. The combined organic extracts
are then washed three times with brine solution, dried over
anhydrous Na2SO4, and concentrated by removal of the solvent.
Further purification is achieved by column chromatography (silica
gel; hexane/ether/NH4OH (trace)). The 2-(4,5-diphenyl-1H-imida-
zol-1-yl)-1-phenylethanol (20) is reacted with CF3SO3H according
to general procedure B. Compound 23 is isolated. 1H NMR (CDCl3):
δ 6.82 (d, J ) 7.3 Hz, 1H), 7.31-7.35 (m, 1H), 7.38-7.41 (m,
1H), 7.43-7.45 (m, 1H), 7.51-7.58 (m, 3H), 7.75-7.78 (m, 3H),
8.12 (d, J ) 8.3 Hz, 1H), 8.14 (s, 1H). 13C NMR (CDCl3): δ 114.3,
121.0, 122.6, 123.1, 125.5, 127.0, 127.3, 127.7, 127.9, 128.0, 128.6,
129.6, 135.5, 136.4. Low resolution MS (EI): 244 (M+), 243, 216,
189, 108. High resolution MS (EI), C17H12N2 calcd: 244.09979,
found 244.10005.
1-(2-(2,4-Dichlorophenyl)-2-phenylethyl)-1H-imidazole (35). Mi-
conazole nitrate salt (0.2 g, 4.2 mmol) is suspended in 4 mL of
CHCl3, and the solution is washed with 1.0 M NaOH and then
brine. The chloroform solution is then dried over MgSO4, filtered,
and added directly to a solution of C6H6 (1 mL) and CF3SO3H (3
mL) with stirring. After stirring at 25 °C for 4 h, the reaction is
worked up according to general experimental procedure A. Com-
1
pound 35: H NMR (CDCl3): δ 4.58 (d, J ) 7.8 Hz, 2H), 4.86 (t,
J ) 7.8 Hz, 1H), 6.81 (s, 1H), 6.99 (s, 1H), 7.20 (d, J ) 7.1 Hz,
2H), 7.25-7.33 (m, 5H), 7.39 (d, J ) 2.0 Hz, 1H), 7.49 (m, 1H).
13C NMR (CDCl3): δ 48.1, 51.0, 119.1, 127.6, 127.7, 128.0, 128.5,
129.0, 129.2, 130.0, 133.7, 135.0, 136.8, 137.2, 138.8. Low
resolution MS (EI): 283/281 (M-35/37), 235/237, 165. High
resolution MS (EI), C17H14N2Cl2 calcd: 316.0534, found 316.0536.
2-(1,2-Diphenylethyl)-1-methyl-1H-imidazole (42). Using general
procedure A, compound 40 is reacted to give product 42 as the
1
major product. Compound 42: H NMR (CDCl3): δ 3.26 (s,3H),
3.29 (dd, J ) 13.4, 8.0, Hz, 1H), 3.75 (dd, J ) 13.4, 8.1 Hz, 1H),
4.14-4.17 (m, 1H), 6.75 (s, 1H), 7.03 (d, J ) 7.0 Hz, 2H), 7.06
(s, 1H), 7.13-7.29 (m, 8H). 13C NMR (CDCl3): δ 32.4, 42.2, 46.1,
120.8, 126.1, 126.7, 127.1, 128.0, 128.1, 128.5, 129.3, 140.1, 141.3,
149.1. Low resolution MS (EI): 262 (M+), 171, 130. High
resolution MS (EI), C18H18N2 calcd: 262.14700, found 262.14696.
2-(2,2-Diphenylethyl)-1-methyl-1H-imidazole (44). Using general
procedure A (modified by dissolving 40 in CHCl3, heating to 50
°C for 1 h, and then adding C6H6), compound 40 is reacted to give
product 44 as the major product. Compound 44: 1H NMR (CDCl3):
δ 3.05 (s, 3H), 3.38 (d, J ) 7.7 Hz, 2H), 4.65 (t, J ) 7.7 Hz, 1H),
6.44 (s, 1H), 6.98 (s, 1H), 7.17-7.21 (m, 6H), 7.26-7.29 (m, 4H).
13C NMR (CDCl3): δ 32.0, 33.3, 50.1, 120.0, 126.3, 127.5, 128.0,
128.3, 144.0, 146.7. Low resolution MS (EI): 262 (M+), 167, 95.
High resolution MS (EI), C18H18N2 calcd: 262.1470, found 262.1469.
5-(1,2-Diphenylethyl)-1-methyl-1H-imidazole (46). Using general
procedure A, compound 45 is reacted to give product 46 as the
major product. Compound 46: 1H NMR (CDCl3): δ 3.13 (dd, J )
6-Phenyl-5,6-dihydroimidazo[2,1-a]isoquinoline (25). Similar to
the preparation of compound 20, 2-phenylimidazole is reacted with
styrene oxide to prepare 1-phenyl-2-(2-phenyl-1H-imidazol-1-
yl)ethanol (24). Compound 24 is reacted with CF3SO3H according
to general procedure B. Product 25 is isolated. 1H NMR (CDCl3):
δ 4.22 (dd, J ) 7.6, 12.4 Hz, 1H), 4.32 (dd, J ) 5.7, 12.4 Hz, 1H),
4.39 (m, 1H), 6.82 (s, 1H), 6.95 (d, J ) 7.7 Hz, 1H), 7.12 (d, J )
6.9 Hz, 2H), 7.15 (s, 1H), 7.20-7.23 (m, 1H), 7.25-7.28 (m, 3H),
7.34-7.37 (m, 1H), 8.14 (d, J ) 7.7 Hz, 1H). 13C NMR (CDCl3):
2506 J. Org. Chem. Vol. 74, No. 6, 2009